Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cattle Diseases D002418 24 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Song T et al. 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1. 2013 Bioorg. Med. Chem. pmid:23206987
Cheng P et al. The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells. 2013 Cell Death Dis pmid:23392177
Ni Z et al. Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. 2013 Leuk. Lymphoma pmid:23398207
Huo M et al. Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. 2013 Int. Immunopharmacol. pmid:23352443
Goff DJ et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. 2013 Cell Stem Cell pmid:23333150
Anderson MA et al. BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia. 2013 Leuk. Lymphoma pmid:23339446
Kannan A et al. Effect of feeding of calcium hydroxide-treated or vitamin E-supplemented cottonseed meal on plasma gossypol levels, blood parameters, and performance of Bikaneri lambs. 2013 Trop Anim Health Prod pmid:23345064
Ansari N et al. Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy. 2013 Methods Cell Biol. pmid:23317907
Senarisoy M et al. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks. 2013 Cell Biochem. Biophys. pmid:23161103
Karaca B et al. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. 2013 Mol. Biol. Rep. pmid:23269627
Soderquist R et al. Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo. 2013 Leukemia pmid:23640104
Granchi C et al. Small-molecule inhibitors of human LDH5. 2013 Future Med Chem pmid:24175747
Zhang Z et al. Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors. 2013 Eur J Med Chem pmid:23314054
Zhong S et al. (-)-Gossypol-enriched cottonseed oil inhibits proliferation and adipogenesis of human breast pre-adipocytes. 2013 Anticancer Res. pmid:23482766
Varadarajan S et al. Sabutoclax (BI97C1) and BI112D1, putative inhibitors of MCL-1, induce mitochondrial fragmentation either upstream of or independent of apoptosis. 2013 Neoplasia pmid:23633928
Semon B Dietary intake of cottonseed toxins is hypothesized to be a partial cause of Alzheimer's disorder. 2012 Med. Hypotheses pmid:22136946
Pond GR et al. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. 2012 Clin Genitourin Cancer pmid:23000202
Ilkevych NS et al. Vibrational spectra, structure and antioxidant activity of gossypol imine derivatives. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:22078080
Sonpavde G et al. Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer. 2012 Ann. Oncol. pmid:22112969
Pond GR et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. 2012 Eur. Urol. pmid:21715086
Azab B et al. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells. 2012 J. Cell. Physiol. pmid:21780116
Imai A et al. Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. 2012 Cancer Res. pmid:22158856
Rathore KS et al. Ultra-low gossypol cottonseed: generational stability of the seed-specific, RNAi-mediated phenotype and resumption of terpenoid profile following seed germination. 2012 Plant Biotechnol. J. pmid:21902797
Mazumder S et al. Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells. 2012 Cancer Res. pmid:22525702
El-Mokadem MY et al. Alleviation of reproductive toxicity of gossypol using selenium supplementation in rams. 2012 J. Anim. Sci. pmid:22585803
Cheng W et al. [Effects of gossypol acetate on apoptosis in primary cultured cells from patients with lymphoid leukemia and its synergy with dexamethasone]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22541072
Zhang YS et al. Gossypol exhibits a strong influence towards UDP-glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-mediated metabolism of xenobiotics and endogenous substances. 2012 Molecules pmid:22543504
Zubair H et al. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage. 2012 Eur J Pharm Sci pmid:22554693
Yang X et al. Identification and proteomic analysis of a novel gossypol-degrading fungal strain. 2012 J. Sci. Food Agric. pmid:22002592
Mellon JE et al. Inhibitory effects of gossypol, gossypolone, and apogossypolone on a collection of economically important filamentous fungi. 2012 J. Agric. Food Chem. pmid:22324794
Özdoğan M et al. Effect of gossypol on blood serum parameters and small intestinal morphology of male broilers. 2012 J Anim Physiol Anim Nutr (Berl) pmid:21261752
Ionov M et al. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. 2012 Int. J. Biol. Macromol. pmid:22910577
Hedvat M et al. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. 2012 Anticancer Agents Med Chem pmid:22931411
Varadarajan S et al. A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. 2012 Cell Death Differ. pmid:22955944
Wang AP et al. Effects of different sources and levels of dietary gossypol on gossypol residues in plasma and milk of lactating cows. 2012 J. Dairy Sci. pmid:22916918
Schuler MA Insect P450s: mounted for battle in their war against toxins. 2012 Mol. Ecol. pmid:22924794
Yang J et al. Synthesis and antiviral activities of novel gossypol derivatives. 2012 Bioorg. Med. Chem. Lett. pmid:22226654
Jiang J et al. Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. 2012 Clin. Exp. Metastasis pmid:22167622
Chien CC et al. The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells. 2012 J. Cell. Physiol. pmid:22170686
Masood A et al. Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. 2012 Br. J. Haematol. pmid:22171982
Lian J et al. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation. 2012 Mol. Cancer Ther. pmid:22188816
Li HQ et al. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. 2012 Bioorg. Med. Chem. pmid:22739087
Ignatova M et al. Quaternized chitosan-coated nanofibrous materials containing gossypol: preparation by electrospinning, characterization and antiproliferative activity towards HeLa cells. 2012 Int J Pharm pmid:22728261
Sun P et al. Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells. 2012 Oncol. Rep. pmid:22766741
Lin H et al. A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies. 2012 J Pharm Biomed Anal pmid:22483642
Billard C Development of Noxa-like BH3 mimetics for apoptosis-based therapeutic strategy in chronic lymphocytic leukemia. 2012 Mol. Cancer Res. pmid:22466256
An T et al. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. 2012 Antiviral Res. pmid:22426469
Tao XY et al. Gossypol-enhanced P450 gene pool contributes to cotton bollworm tolerance to a pyrethroid insecticide. 2012 Mol. Ecol. pmid:22515600
Wagner TA et al. Hemigossypol, a constituent in developing glanded cottonseed (Gossypium hirsutum). 2012 J. Agric. Food Chem. pmid:22369216
Kisim A et al. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. 2012 J. Cancer Res. Clin. Oncol. pmid:22411600
Bodur C and Basaga H Bcl-2 inhibitors: emerging drugs in cancer therapy. 2012 Curr. Med. Chem. pmid:22414090
Hsiao WT et al. Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells. 2012 Mol. Vis. pmid:22876131
Wong FY et al. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression. 2012 PLoS ONE pmid:23226540
Sarwar Gilani G et al. Impact of antinutritional factors in food proteins on the digestibility of protein and the bioavailability of amino acids and on protein quality. 2012 Br. J. Nutr. pmid:23107545
Vshivkov S et al. Capillary electrophoresis to quantitate gossypol enantiomers in cotton flower petals and seed. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23122406
Zbidah M et al. Gossypol-induced suicidal erythrocyte death. 2012 Toxicology pmid:23041711
Thakur A et al. Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. 2012 PLoS ONE pmid:23185240
Jackson RS et al. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. 2012 Neoplasia pmid:22904682
Hu W et al. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. 2012 J. Biol. Chem. pmid:22052903
Shen Y and Ye D Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. 2012 Eur. Urol. pmid:21824719
Wang Y et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. 2011 Mol. Endocrinol. pmid:22053001
Ready N et al. Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. 2011 J Thorac Oncol pmid:21289522
Zhou DR et al. [Gossypol decreases the expression of connexin 43 in Sertoli cells]. 2011 Zhonghua Nan Ke Xue pmid:22141269
Williams JL et al. Fitness cost of resistance to Bt cotton linked with increased gossypol content in pink bollworm larvae. 2011 PLoS ONE pmid:21738799
Chang Q et al. Drug synergistic antifertility effect of combined administration of low-dose gossypol with steroid hormones in rats. 2011 Chin. Med. J. pmid:21740776
Gunassekaran GR et al. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. 2011 Biochem. Biophys. Res. Commun. pmid:21782799
Yin J et al. Novel O-glycosidic gossypol isomers and their bioactivities. 2011 Carbohydr. Res. pmid:21788013
Ouyang DY et al. Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis. 2011 J Proteomics pmid:21726675
Li H et al. Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells. 2011 Pharm. Res. pmid:21710341
Dash R et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21555592
Pang X et al. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. 2011 Mol. Cancer Ther. pmid:21372225
Guo Z et al. [Gossypol acetic acid induces DNA double-strand breaks in human mucoepidermoid carcinoma cell MEC-1]. 2011 Sheng Li Xue Bao pmid:21505732
Ma X et al. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. 2011 Toxicology pmid:21515335
Mao YB et al. Cotton plants expressing CYP6AE14 double-stranded RNA show enhanced resistance to bollworms. 2011 Transgenic Res. pmid:20953975
Moon DO et al. Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. 2011 Food Chem. Toxicol. pmid:21223991
Mellon JE et al. Inhibitory effects of gossypol-related compounds on growth of Aspergillus flavus. 2011 Lett. Appl. Microbiol. pmid:21291481
Le TT et al. Evidence for a trianion intermediate in the metalation of 4-hydroxy-6,7-dimethoxy-8-methyl-2-naphthoic acid. Methodology and application to racemic 5,5'-didesisopropyl-5,5'-dialkylapogossypol derivatives. 2011 J. Org. Chem. pmid:21174400
Hu ZY et al. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. 2011 Chin J Cancer pmid:21192843
Baggstrom MQ et al. A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. 2011 J Thorac Oncol pmid:21918390
Lu Z et al. Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. 2011 J. Nat. Prod. pmid:21280591
Zhang P et al. Suppression of jasmonic acid-dependent defense in cotton plant by the mealybug Phenacoccus solenopsis. 2011 PLoS ONE pmid:21818315
Lian J et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. 2011 Cell Death Differ. pmid:20577262
Spagnuolo C et al. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. 2011 Br. J. Cancer pmid:21750559
Amm HM et al. Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. 2011 Mol. Cancer Res. pmid:21357440
Granchi C et al. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. 2011 J. Med. Chem. pmid:21332213
Celorio-Mancera Mde L et al. Transcriptional responses underlying the hormetic and detrimental effects of the plant secondary metabolite gossypol on the generalist herbivore Helicoverpa armigera. 2011 BMC Genomics pmid:22111916
Akagunduz O et al. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. 2010 Oct-Dec J BUON pmid:21229643
Tiliabaev KZ et al. [Synthesis, structures, and acute toxicity of gossypol nonsymmetrical aldehyde derivatives]. 2010 May-Jun Bioorg. Khim. pmid:20644599
Fulda S Modulation of apoptosis by natural products for cancer therapy. 2010 Planta Med. pmid:20486070
Ionov M et al. The interaction of PVP complexes of gossypol and its derivatives with an artificial membrane lipid matrix. 2010 Cell. Mol. Biol. Lett. pmid:19936629
Blevins S et al. Effects of silymarin on gossypol toxicosis in divergent lines of chickens. 2010 Poult. Sci. pmid:20709972
Yan F et al. A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer. 2010 J. Med. Chem. pmid:20684596
Wu G et al. Responses of three successive generations of beet armyworm, Spodoptera exigua, fed exclusively on different levels of gossypol in cotton leaves. 2010 J. Insect Sci. pmid:21067414
Wei J et al. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. 2010 J. Med. Chem. pmid:21033669
ZHU Y et al. Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells. 2010 Acta Pharmacol. Sin. pmid:21102482
Barelier S et al. Fragment-based deconstruction of Bcl-xL inhibitors. 2010 J. Med. Chem. pmid:20192224
Le A et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20133848
Zhang XQ et al. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol. 2010 Asian J. Androl. pmid:20081872
Liu YX Temperature control of spermatogenesis and prospect of male contraception. 2010 Front Biosci (Schol Ed) pmid:20036980
Wang H et al. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells. 2010 J. Biochem. pmid:19880376